Plain-English translation of NCT07435454 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new approach for people with advanced esophageal cancer that cannot be surgically removed. The study combines paclitaxel, an oral medication (taken by mouth as a pill), with radiation therapy to see if it works and is safe for patients who are older or unable to tolerate traditional intravenous chemotherapy. Researchers want to learn whether this gentler approach can help people with this serious diagnosis.
Many patients with advanced esophageal cancer cannot receive standard chemotherapy because of age, other health conditions, or severe difficulty swallowing. This trial exists because there is a real need to find effective treatment options for these patients who are often left with few choices.
You likely qualify if…
You likely don't qualify if…
As a participant, you would take the oral medication regularly while receiving radiation therapy treatments over several weeks. You would attend appointments at the hospital for radiation sessions and follow-up visits to check how well the treatment is working and monitor for any side effects. The study involves blood tests and imaging scans to evaluate your response to the treatment, and you would continue to be monitored after the initial treatment period ends.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China